Cargando…
Improving Immunotherapy Through Glycodesign
Immunotherapy is revolutionizing health care, with the majority of high impact “drugs” approved in the past decade falling into this category of therapy. Despite considerable success, glycosylation—a key design parameter that ensures safety, optimizes biological response, and influences the pharmaco...
Autores principales: | Buettner, Matthew J., Shah, Sagar R., Saeui, Christopher T., Ariss, Ryan, Yarema, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224361/ https://www.ncbi.nlm.nih.gov/pubmed/30450094 http://dx.doi.org/10.3389/fimmu.2018.02485 |
Ejemplares similares
-
A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution
por: Chen, Yen-Hsi, et al.
Publicado: (2023) -
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression
por: Saeui, Christopher T., et al.
Publicado: (2020) -
Cell Surface and Membrane Engineering: Emerging Technologies and Applications
por: Saeui, Christopher T., et al.
Publicado: (2015) -
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs
por: Du, Jian, et al.
Publicado: (2021) -
Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering
por: Stabach, Paul R., et al.
Publicado: (2020)